Emerging studies suggest Retatrutide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , may offer a notable development for weight management . Preliminary https://bookmarkingalpha.com/story21552100/the-retatrutide-peptide-compound-a-innovation-in-weight-management